Product Search |
|
Input Product Name Or Cas No. |
Category |
Products |
1H-Isoindole, 4-bromo-2-cyclopropyl-2,3- |
1H-Isoindole, 4-bromo-2-(2,2-dimethylpro |
1H-Isoindole, 4-bromo-2,3-dihydro-6-meth |
Methyl 3-bromo-4,6-dichloro-2-pyridineca |
tert-butyl 4-(((4-(1-cyclopropyl-3-ethox |
ethyl 3-cyclopropyl-3-(2-(piperidin-4-yl |
Methyl 5-bromo-3-[[4-[[(1,1-dimethyletho |
1-(1,1-Dimethylethyl) 4-[(3-carboxy-5-ch |
5-Bromo-7-fluoro-2,3-dihydro-2-methyl-1H |
1-Piperidinecarboxylic acid, 4-[[(4-brom |
1-Piperidinecarboxylic acid, 4-[[[4-(4,4 |
Ethyl 2-methyl-3-[(phenylmethyl)amino]be |
Benzoic acid, 5-methoxy-2-methyl-3-nitro |
Benzoic acid, 3-(cyclopentylamino)-2-met |
3-(Aminomethyl)-1-(2-hydroxyethyl)-4,6-d |
1,1-Dimethylethyl 3-[[5-chloro-3-(methox |
1,1-Dimethylethyl 3-[[5-chloro-3-(methox |
Benzoic acid, 5-chloro-3-[ethyl(1-methyl |
Benzoic acid, 5-chloro-3-[ethyl(1-methyl |
Benzoic acid, 5-chloro-3-[ethyl(1-methyl |
Benzoic acid, 5-chloro-3-(cyclohexylamin |
Benzoic acid, 5-chloro-3-(cyclohexylmeth |
5-Chloro-3-(cyclohexylmethylamino)-2-met |
Benzoic acid, 5-chloro-3-(cyclopentylami |
Benzoic acid, 5-chloro-3-(cyclopentylmet |
5-Chloro-3-(cyclopentylmethylamino)-2-me |
1,1-Dimethylethyl 4-[[5-chloro-3-(methox |
1-(1,1-Dimethylethyl) 4-[(3-carboxy-5-ch |
Benzoic acid, 2,5-dichloro-3-(cyclopenty |
Benzoic acid, 2,5-dichloro-3-(cyclopenty |
2,5-Dichloro-3-(cyclopentylmethylamino)b |
Benzoic acid, 5-chloro-2-methyl-3-[methy |
5-Chloro-2-methyl-3-[methyl(tetrahydro-2 |
5-Bromo-3-[[4-[[(1,1-dimethylethoxy)carb |
Benzoic acid, 3-(cyclopentylmethylamino) |
3-(Cyclopentylmethylamino)-2-methylbenzo |
5-Bromo-3-[[4-[[(1,1-dimethylethoxy)carb |
5-Bromo-3-(cyclohexylamino)-2-methylbenz |
Benzoic acid, 5-bromo-2-methyl-3-[methyl |
5-Bromo-2-methyl-3-[methyl(1-methyl-4-pi |
5-Bromo-2-methyl-3-[(tetrahydro-2H-pyran |
Benzoic acid, 3-amino-5-bromo-2,4-dimeth |
Benzoic acid, 5-bromo-3-(cyclopentylamin |
Benzoic acid, 5-bromo-3-(cyclopentylmeth |
5-Bromo-3-(cyclopentylmethylamino)-2,4-d |
Methyl 5-chloro-3-[(cyclopentylcarbonyl) |
5-Chloro-3-[(cyclopentylcarbonyl)methyla |
Methyl 5-chloro-3-[[2-[[(1,1-dimethyleth |
Methyl 5-chloro-3-[[2-[[(1,1-dimethyleth |
5-Chloro-3-[[2-[[(1,1-dimethylethoxy)car |
|
Products |
Catalogue Number |
Products |
CAS No. |
Assay |
Rovathin948 | 3-Methoxypropionitrile | 110-67-8 | 97% |
Rovathin949 | 2-Methyl-4-nitroaniline | 99-52-5 | 97% |
Rovathin950 | 3,5-di-tert-butyl-4-hydroxybenzaldehyde | 1620-98-0 | 97% |
Rovathin951 | 3-Ethoxypropanenitrile | 2141-62-0 | 97% |
Rovathin952 | methyl 3-methoxypropionate | 3852-09-3 | 97% |
Rovathin953 | N-Methylformanilide | 93-61-8 | 97% |
Rovathin954 | 3,4-Dimethoxy benzaldehyde | 120-14-9 | 97% |
Rovathin955 | 1,2,3,4-Tetrahydro-1-naphthoic acid | 1914-65-4 | 97% |
Rovathin956 | 2-Chloro-4-methyl-5-nitropyridine | 23056-33-9 | 97% |
Rovathin957 | Tri(o-tolyl)phosphine | 6163-58-2 | 97% |
Rovathin958 | Ethyl fluoroacetate | 459-72-3 | 97% |
Rovathin959 | Methyl fluoroacetate | 453-18-9 | 97% |
Rovathin960 | 5-Fluorouracil | 51-21-8 | 97% |
Rovathin961 | 2-Ethoxy-5-fluorouracil | 56177-80-1 | 97% |
Rovathin962 | 5-Fluorocytosine | 2022-85-7 | 97% |
Rovathin963 | 5-Fluorouridine | 316-46-1 | 97% |
Rovathin964 | 4-Chlorobenzenesulfonic acid | 98-66-8 | 97% |
Rovathin965 | 2-(3-Amino-4-chlorobenzoyl)benzoic acid | 118-04-7 | 97% |
Rovathin966 | 2,4-Dichloro-5-bromopyrimidine | 36082-50-5 | 97% |
Rovathin967 | Methyl 4-methyl-5-thiazolecarboxylate | 81569-44-0 | 97% |
Rovathin968 | 5-Bromouracil | 51-20-7 | 97% |
Rovathin969 | 2,4-Dichloro-5-fluoro-pyrimidine | 2927-71-1 | 97% |
Rovathin970 | Potassium Ethyl Malonate | 6148-64-7 | 97% |
Rovathin971 | 4,5-dicyano-2-aminoimidazole | 40953-34-2 | 98% |
Rovathin972 | 2,2-Dimethyl-1,3-dioxane-4,6-dione | 2033-24-1 | 97% |
Rovathin973 | Diethyl 2-butylmalonate | 133-08-4 | 97% |
Rovathin974 | Formamidine acetate salt | 3473-63-0 | 97% |
Rovathin975 | 3-Cyano-2,6-dihydroxy-5-fluoropyridine | 113237-18-6 | 97% |
Rovathin976 | 2,6-Dichloro-5-Fluoronicotinic Acid | 82671-06-5 | 97% |
Rovathin977 | 5-Fluoro-4-hydroxypyrimidine | 671-35-2 | 97% |
|
|
|
|